Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer

Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion

(2012) Huan Yang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis

(2010) Salomé González-Reyes et al.   BMC CANCER

High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer

(2010) E L Wang et al.   BRITISH JOURNAL OF CANCER

Toll-like receptor 2 mediates invasion via activating NF-κB in MDA-MB-231 breast cancer cells

(2009) Wenjie Xie et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

 1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer

(2009) D. Lesniak et al.   CANCER RESEARCH

When Signaling Pathways Collide: Positive and Negative Regulation of Toll-like Receptor Signal Transduction

(2008) Luke A.J. O'Neill   IMMUNITY

Increased expression of Toll-like receptors 4 and 9 in human lung cancer

(2008) Yan-Bei Zhang et al.   MOLECULAR BIOLOGY REPORTS

TLR signaling by tumor and immune cells: a double-edged sword

(2008) B Huang et al.   ONCOGENE